What RGEN Inc. does

RGEN Inc. is a privately-held end-to-end genomics services company headquartered in Morgantown, West Virginia, co-located at the West Virginia University Innovation Corporation. Founded circa 2022-2023, the company operates with a small team of approximately 7 employees across offices in Morgantown (HQ), Huntington (WV), Houston (TX), and a planned Charleston (WV) location. RGEN provides integrated genomic workflow services spanning sample collection, wet-lab processing, dry-lab bioinformatics analysis, logistics, biobanking, and actionable report delivery with EHR integration for clinical clients.

The company's service portfolio is organized into eight core service lines — Forensic Genetics, Genomic Pipeline Development, Direct-to-Consumer Services, Lab Services, Data Analysis, Genomic Logistics, Genomic Research, and Genomic Training Programs — supplemented by clinical solutions (pharmacogenomics, cancer genomics, disease screening, risk assessment), forensic solutions (FIGG, genetic phenotyping, DNA profiling, evidence examination), and white-label DTC infrastructure. Underlying technology is described as a Next Generation Sequencing platform with advanced bioinformatics and integrated EHR connectivity. Documented use cases include cold case resolution via Forensic Investigative Genetic Genealogy for law enforcement, clinical-trial-accelerating pipeline development for a major pharmaceutical client, and epigenetic/carrier-screening enablement for a DTC genomics partner.

RGEN's revenue model is primarily fee-for-service professional services (genomic testing, pipeline development) complemented by managed services in logistics and biobanking and white-label partnerships with DTC companies. Pricing is quote-based and not publicly disclosed. The company also operates an ancillary e-commerce shop on its website selling telescopes and microscopes, which appears supplementary to the core genomic business and is not tied to the documented genomic offerings. RGEN has no disclosed funding rounds, no public ownership or investor list, no certifications or compliance information, and no disclosed revenue figures.

Name

RGEN Inc.

Legal name

RGEN Inc.

Website

https://rgeninc.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

RGEN Inc. is a privately-held, end-to-end genomics services company headquartered in Morgantown, West Virginia, providing integrated wet-lab, bioinformatics, forensic genetic genealogy, pharmacogenomics, and white-label DTC infrastructure to healthcare, pharmaceutical, research, government, and law-enforcement clients.

Ownership category

akta.pro rank

Product category

Genomic Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Genomic services
• Forensic genetics
• Pharmacogenomics
• Biobanking logistics
• Precision medicine

Headquarters

HQ city

Houston, Texas

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Genomic Testing Services: Fee-for-service model providing genetic testing across multiple domains including forensic genetics, pharmacogenomics, carrier screening, cancer genomics, and disease screening. Services include both wet lab (sample processing) and dry lab (data analysis) components.
2. Laboratory Services: High-throughput genomics lab services providing advanced testing capabilities for clinical and research applications. Adaptable to various project sizes and types, serving diverse genomic needs.
3. Logistics & Biobanking Services: Third-party biomedical logistics management, secure biobanking with affordable annual fees, and private label/branding options for clients seeking to offer genomic services under their own brand.
4. Genomic Pipeline Development & Consulting: Custom genomic pipeline strategic planning, design, and implementation services including EHR integration and workflow optimization for pharmaceutical and healthcare clients.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

RGEN Inc. is an end-to-end genomic services company that provides wet lab, dry lab, logistics, biobanking, and bioinformatics solutions. The company supports forensic genetics, pharmacogenomics, cancer genomics, disease screening, and direct-to-consumer genomic offerings through partnerships. The company also operates a small e-commerce shop selling optical equipment such as telescopes and microscopes.

Product overview

RGEN Inc. is an end-to-end genomics services company offering a unified platform combining eight core service lines: Forensic Genetics, Genomic Pipeline Development, Direct-to-Consumer Services, Lab Services, Data Analysis, Genomic Logistics, Genomic Research, and Genomic Training Programs. These operate alongside specialized clinical solutions including Pharmacogenomics, Disease Screening, Cancer Genomics, and Risk Assessment; DTC Solutions for ancestry testing, wellness genomics, and carrier screening; Forensic Solutions using Forensic Investigative Genetic Genealogy (FIGG) for genetic genealogy, DNA profiling, and evidence examination; and Logistics & Storage Solutions providing biomedical logistics, biobanking, and private label services. The company also maintains a supplementary e-commerce shop section selling microscopes and telescopes.

Differentiator

Problem solved

Functional benefit

Products and services

• Forensic Genetics Genomic testing and analysis services tailored for forensic identification, investigative genetic genealogy (FIGG), and law enforcement casework. Designed for forensic laboratories, government agencies, and investigative teams requiring DNA-based identification and kinship analysis.
• Genomic Pipeline Development Custom design and development of genomic sequencing and analysis pipelines for institutional clients. Targeted at healthcare organizations, pharmaceutical companies, and research institutions seeking to build or scale in-house genomic capabilities.
• Direct-to-Consumer (DTC) Genomic Services White-label and partner-branded genomic testing services delivered through DTC companies. RGEN serves as the laboratory and bioinformatics backend for partner DTC brands offering ancestry, wellness, and trait-based genetic reports to consumers.
• Lab Services Fee-for-service laboratory offerings including next-generation sequencing (NGS), sample processing, and nucleic acid extraction. Provided to research institutions, clinical labs, and partner organizations that outsource wet-lab work.
• Data Analysis (Bioinformatics) Bioinformatics and computational genomic data analysis, including variant calling, interpretation, and reporting. Aimed at clinicians, researchers, and pharmaceutical partners who require expert genomic data interpretation without in-house bioinformatics capacity.
• Genomic Logistics Sample collection kit fulfillment, biobanking, cold-chain logistics, and sample tracking for genomic specimens. Designed for clinics, biobanks, research projects, and population-scale studies that require coordinated sample handling.
• Genomic Research Services Research-grade genomic services supporting academic and commercial research projects, including population genomics, disease studies, and exploratory sequencing. Delivered to university labs, research consortia, and biotech R&D teams.
• Genomic Training Programs Educational and training services covering genomic technologies, bioinformatics, and laboratory techniques. Targeted at institutions, professionals, and partner organizations seeking workforce upskilling in genomics.
• Pharmacogenomics Pharmacogenomic testing that analyzes how an individual's genetics affect drug response. Delivered for healthcare providers, pharmacies, and pharmaceutical partners supporting personalized medication selection.
• Disease Screening Genetic screening services for inherited disease risk, carrier status, and population-level screening programs. Targeted at clinical providers, public health programs, and screening-focused DTC partners.
• Cancer Genomics Oncology-focused genomic services including tumor profiling, hereditary cancer testing, and somatic variant analysis. Designed for oncologists, cancer centers, and pharmaceutical oncology programs.
• Genetic Risk Assessment Polygenic and multifactorial risk assessment services evaluating an individual's genetic predisposition to complex conditions. Delivered to providers, employer wellness programs, and DTC partners offering personalized risk insights.
• RGEN Optical Shop An online retail storefront selling optical equipment including telescopes and microscopes. Sells the company's own curated optical products directly to individual consumers.

Quantifiable outcome

• Expedited clinical trials and significant cost savings for pharmaceutical client through efficient genomic pipeline development
• +2 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• West Virginia University Innovation CorporationcoreStrategic or Co-development PartnerRGEN's headquarters is located within the West Virginia University Innovation Corporation facility in Morgantown, WV. This strategic co-location provides access to academic research resources, talent pipeline from WVU, and collaborative innovation opportunities in the genomics space.
• GenovationminorStrategic or Co-development PartnerListed as a partner/client collaboration on the RGEN website, representing one of the ecosystem relationships in the genomic services community.
• GxG (Gene by Gene)minorStrategic or Co-development PartnerListed as a partner/client collaboration, indicating mutual engagement in the genomic services ecosystem.
• WVUIC (West Virginia University Innovation Corp)coreStrategic or Co-development PartnerPrimary hosting partner and strategic collaborator providing the physical and institutional infrastructure for RGEN's headquarters operations in Morgantown.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Othram: Othram specializes in forensic genomics and advanced DNA analysis for difficult investigations, including genetic-genealogy applications. It is a direct niche peer to RGEN's FIGG and law-enforcement offering.
• Color Health: Color Health combines population genomics, genetic testing, and precision-health programs for healthcare and consumer-facing applications. It overlaps with RGEN's healthcare, DTC, testing, and genomic data-analysis offerings.
• Fulgent Genetics: Fulgent Genetics operates an integrated genetic-testing and bioinformatics platform spanning clinical, research, and consumer applications. It is a direct operational peer to RGEN's wet-lab, dry-lab, and genomic data-analysis services.
• Gene By Gene: Gene By Gene provides genomic laboratory and testing services, including genetic genealogy, ancestry, clinical, research, and sequencing offerings. Its laboratory and data capabilities closely overlap RGEN's genomic-services model.
• Verogen: Verogen provides forensic sequencing and genetic-genealogy products and services. Its focus on investigative genetic genealogy directly overlaps RGEN's specialized FIGG capability.
• PreventionGenetics: PreventionGenetics is a clinical genetic-testing laboratory offering sequencing, variant interpretation, and related research services. It is comparable to RGEN's molecular testing and bioinformatics workflow.
• Bode Technology: Bode Technology provides forensic DNA testing, human identification, and evidence-examination services. It is comparable to RGEN's forensic-genetics work, although RGEN also spans clinical and research genomics.
• Nebula Genomics: Nebula Genomics offers consumer whole-genome sequencing and genomic data services. It is relevant to RGEN's DTC genomics, ancestry, wellness, and data-infrastructure capabilities, though its go-to-market model is more consumer branded.

Broad incumbents

• QIAGEN: QIAGEN provides molecular-diagnostics, sample-preparation, and bioinformatics products used in genomic workflows. It is a broad incumbent and ecosystem peer to RGEN's laboratory, bioinformatics, and molecular-testing activities.
• Natera: Natera operates an established clinical genetic-testing laboratory with broad genomic-analysis capabilities. It is a broad incumbent comparable to RGEN's laboratory and clinical genomics services, but with a more specialized clinical-testing focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/rgeninc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RGEN Inc.